73247026
voted
Good day, traders. Happy Wednesday, Aug 7th. The market is rebounding thanks to a lighter earnings week, and lower volatility overall. My name is Kevin Travers; here are stories herd on Wall Street: these are today's moovin' stonks.
$Novo-Nordisk A/S (NVO.US)$, the Wegovy and Ozempic seller saw its stock fell 7% after the firm said on Wednesday its profit rose 3% to 20 billion Danish kroner ($2.93 billion), or 4.49 kroner a share...
$Novo-Nordisk A/S (NVO.US)$, the Wegovy and Ozempic seller saw its stock fell 7% after the firm said on Wednesday its profit rose 3% to 20 billion Danish kroner ($2.93 billion), or 4.49 kroner a share...
14
6
73247026
liked and voted
$Palantir (PLTR.US)$ investors who held on to their bullish call options at a time when the stock was wavering, are benefiting after the tech company provided a rosier outlook and better-than-expected second quarter financial results.
Shares of the company that builds and deploys software platforms advanced 12% Tuesday after boosting its revenue outlook, taking it above analyst estimates. It also reported record profit...
Shares of the company that builds and deploys software platforms advanced 12% Tuesday after boosting its revenue outlook, taking it above analyst estimates. It also reported record profit...
49
10
$Tesla (TSLA.US)$ should i sell my tesla tommorow or yall think it will go up still ?
2
3
73247026
voted
Columns Tesla Attracts $190 Million in Short Call Positions Even as Stock Soars After Deliveries Beat
$Tesla (TSLA.US)$attracted almost $190 million in short call positions at a time when the stock is soaring to its highest level since January.
Shares of the electric vehicle maker jumped 9% to $228.83 Tuesday after Tesla reported second quarter deliveries that beat analysts' estimates. Wedbush analyst Daniel Ives said the results represented "a huge comeback performance" for the company that's widely expe...
Shares of the electric vehicle maker jumped 9% to $228.83 Tuesday after Tesla reported second quarter deliveries that beat analysts' estimates. Wedbush analyst Daniel Ives said the results represented "a huge comeback performance" for the company that's widely expe...
68
14